Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have been used as standard therapy for patients with advanced renal cell carcinoma (RCC). However, information on factors predicting response to treatment with TKIs is lacking. This study aimed to assess the association between initial tumor size, involv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tsuchiya, Norihiko, Yuasa, Takeshi, Maita, Shinya, Narita, Shintaro, Inoue, Takamitsu, Numakura, Kazuyuki, Saito, Mitsuru, Satoh, Shigeru, Yonese, Junji, Habuchi, Tomonori
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3975282/
https://ncbi.nlm.nih.gov/pubmed/24612599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2490-14-26
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados